The PAMREVLUmab Biosimilar Anti-CCN2 Antibody is a cutting-edge research tool designed for studying the role of CCN2, a key factor in fibrosis and tissue regeneration. This monoclonal antibody, developed as a biosimilar to the original PAMREVLUmab, targets the CCN2 protein with high specificity and sensitivity in a variety of experimental settings.CCN2, also known as connective tissue growth factor, is a multifunctional protein involved in the regulation of cell proliferation, differentiation, and extracellular matrix production. Its dysregulation has been linked to fibrotic diseases, cancer progression, and tissue repair processes.
The PAMREVLUmab Biosimilar Anti-CCN2 Antibody enables researchers to investigate the expression, localization, and function of CCN2 in different cell types and disease models.By utilizing this antibody in techniques such as immunofluorescence, immunohistochemistry, and flow cytometry, scientists can gain valuable insights into the molecular mechanisms underlying fibrosis, cancer development, and wound healing. The PAMREVLUmab Biosimilar Anti-CCN2 Antibody is a reliable tool for advancing our understanding of CCN2 biology and exploring its therapeutic potential in various pathological conditions.
Product Name:
Pamrevlumab (Anti-CCN2) Biosimilar Antibody
Size:
100 ug
Product SKU:
HDBS0108
Target:
CCN2
Host Species:
Homo sapiens
Reactivity:
Human
Recommended Dilution:
Flow Cyt 1:100
Antibody Type:
Monoclonal
Buffer:
Lyophilized from sterile PBS, pH 7.4. Normally 5 % - 8% trehalose is added as protectants before lyophilization. Please see Certificate of Analysis for specific instructions.
Storage & Shipping:
Store at -20°C to -80°C for 12 months in lyophilized form. After reconstitution, if not intended for use within a month, aliquot and store at -80°C (Avoid repeated freezing and thawing).Lyophilized antibodies are shipped at ambient temperature.
Common Name:
FG-3019
Description:
Anti-CCN2(pamrevlumab biosimilar) mAb
Buffer:
Lyophilized from sterile PBS, pH 7.4. Normally 5 % - 8% trehalose is added as protectants before lyophilization. Please see Certificate of Analysis for specific instructions.
Format:
Powder
Applications
Flow Cyt
Antibody Isotype:
IgG1
Guarantee:
12 months from date of dispatch
Background:
Research grade biosimilar. Not for use in therapeutic or diagnostic procedures for humans or animals.
